Clinical trials
Phase 1 Hepatitis B trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
86 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 7 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 6 |
| 2019 | 9 |
| 2020 | 7 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 7 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 61 |
| Recruiting | 8 |
| Terminated | 6 |
| Unknown status | 5 |
| Active, not recruiting | 3 |
| Not yet recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 8 |
| Assembly Biosciences | 4 |
| Dynavax Technologies Corporation | 4 |
| Enanta Pharmaceuticals, Inc | 4 |
| Gilead Sciences | 4 |
| Alios Biopharma Inc. | 3 |
| Fujian Cosunter Pharmaceutical Co. Ltd | 3 |
| Dong-A ST Co., Ltd. | 2 |
| Hoffmann-La Roche | 2 |
| LG Chem | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis B | 86 |
| Hepatitis B, Chronic | 25 |
| Hepatitis | 5 |
| Carcinoma, Hepatocellular | 4 |
| Virus Diseases | 4 |
| Hepatitis C | 3 |
| Liver Diseases | 3 |
| Communicable Diseases | 2 |
| Diphtheria | 2 |
| Fibrosis | 2 |
Trials
Showing 76 to 86 of 86. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.